In the last three months, 5 analysts have published ratings on Tandem Diabetes Care (NASDAQ:TNDM), offering a diverse range of perspectives from bullish to bearish.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $48.6, with a high estimate of $65.00 and a low estimate of $42.00. Surpassing the previous average price target of $45.00, the current average has increased by 8.0%.

Exploring Analyst Ratings: An In-Depth Overview

An in-depth analysis of...